Hear from our experts

First introduced in 1925 at the Mayo Clinic, the Goeckerman regimen combines ultraviolet B (UVB) phototherapy with a therapeutic tar to treat moderate to severe psoriasis. These two therapies work together to reduce inflammation, slow the overgrowth of skin cells, and rapidly improve symptoms. The result is high rates of skin clearance that remain competitive with many modern biologic medications.

Today, Solay's telehealth model and digital treatment tools have allowed Goeckerman therapy to evolve once again. It can now be delivered in a supervised at-home format that preserves the effectiveness of the traditional regimen while dramatically improving access, convenience, and scalability. Even with the availability of newer systemic medications, Goeckerman therapy remains one of the most effective, durable, and safest treatment options for patients with plaque psoriasis and eczema.

The Goeckerman therapy remains one of the most effective treatments for psoriasis and eczema. It has even been used successfully in patients who were treatment-resistant and in patients who have contraindications to biologic medications.

For Psoriasis:

A study examining 300 patients in both Baylor University and UCSF's Goeckerman centers found that 100% of psoriasis patients achieved 90% improvement in the PASI score (PASI 90), with 73% of patients remaining in remission for at least 12 months.

For Eczema:

A study at UCSF found that 80% of patients who were treated with Goeckerman achieved greater than 90% skin clearance with an average remission of 7.2 months.

The safety profile of Goeckerman therapy is excellent and does not carry the same internal risks as biologics. Since the side effects of Goeckerman therapy are minimal, the regimen can be used in everyone including the elderly, children, patients with history of cancer, immunosuppressed patients, and patients with other comorbidities.

In most cases, the treatment ends once your skin has fully resolved. This is often dependent on the patient's medical history and the severity of the condition. Typically, the treatment period is usually 8 weeks, followed by a post-treatment maintenance plan to extend results.

Solay Health treats patients ages 4 and up in California and Illinois. North Carolina and Texas are next, with more states to follow.